Correlation Between Medigen Vaccine and TaiMed Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Vaccine and TaiMed Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Vaccine and TaiMed Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Vaccine Biologics and TaiMed Biologics, you can compare the effects of market volatilities on Medigen Vaccine and TaiMed Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Vaccine with a short position of TaiMed Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Vaccine and TaiMed Biologics.

Diversification Opportunities for Medigen Vaccine and TaiMed Biologics

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Medigen and TaiMed is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Vaccine Biologics and TaiMed Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TaiMed Biologics and Medigen Vaccine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Vaccine Biologics are associated (or correlated) with TaiMed Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TaiMed Biologics has no effect on the direction of Medigen Vaccine i.e., Medigen Vaccine and TaiMed Biologics go up and down completely randomly.

Pair Corralation between Medigen Vaccine and TaiMed Biologics

Assuming the 90 days trading horizon Medigen Vaccine Biologics is expected to generate 1.43 times more return on investment than TaiMed Biologics. However, Medigen Vaccine is 1.43 times more volatile than TaiMed Biologics. It trades about 0.34 of its potential returns per unit of risk. TaiMed Biologics is currently generating about 0.04 per unit of risk. If you would invest  3,705  in Medigen Vaccine Biologics on October 24, 2024 and sell it today you would earn a total of  1,265  from holding Medigen Vaccine Biologics or generate 34.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Medigen Vaccine Biologics  vs.  TaiMed Biologics

 Performance 
       Timeline  
Medigen Vaccine Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Vaccine Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.
TaiMed Biologics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in TaiMed Biologics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, TaiMed Biologics is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Medigen Vaccine and TaiMed Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Vaccine and TaiMed Biologics

The main advantage of trading using opposite Medigen Vaccine and TaiMed Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Vaccine position performs unexpectedly, TaiMed Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TaiMed Biologics will offset losses from the drop in TaiMed Biologics' long position.
The idea behind Medigen Vaccine Biologics and TaiMed Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital